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This letter was submitted to Drs. Kondo and 
Adachi who offer the following reply: 
The meticulous work by Lowry et al [1 ], which 
measured all phosphorylated intermediates 
after acute ischemia, indicated that there are 
three regulatory steps in the brain: hexokinase, 
phosphorylase, and phosphofructokinase. The 
major purpose of our studies on PFK in skin was 
limited to presenting evidence that PFK in skin 
is one of the regulatory enzymes in glycolysis. 
We do not yet have sufficient experimental data 
to show directly whether hexokinase or phos-
phorylase rather than PFK are the key regulatory 
enzymes in the glycolytic pathway in skin. The 
suggestion by Drs. Johnson and Fusaro that 
skin hexokinase is controlled by PFK (directly 
or by G6P) is quite conceivable. We agree with 
their opinion that hexokinase must be purified 
for detailed kinetic studies. We did not discuss 
the G6P inhibition on hexokinase because of a 
lack of adequate information at the present time. 
As for the work of Harkonen and Hopsu-
Havu referred to by Drs. Johnson and Fusaro, we 
wonder whether there is any point of compari-
son between their work and ours. They mea-
sured the ATP level after "prolonged suction" 
(the first experimental point being after one hour), 
during which time many different regulatory 
mechanisms would have intervened. Our mea-
surements, on the other hand, were done within 
seconds and minutes. Obviously to study the 
primary action of an acute control mechanism, the 
primary changes which occur within seconds must 
be measured immediately. In addition, they did 
not measure the levels of phosphorylated sugars 
nor the oxygen concentration of the blister fluid; 
thus their experimental data neither conflict 
with ours nor explain an acute control mech-
anism. At present, we simply submit the possi-
bilities that either ATP or citrate or the combi-
nation of both affect PFK activity. We do not 
have sufficient data to establish a hierarchy 
among ATP, citrate, and other end-products. 
We agree with Drs. Johnson and Fusaro that 
there is a need for definitive in vivo studies of 
glycolytic control in the epidermis. On the other 
hand, we realize that such definitive in vivo 
studies on acute control mechanisms are ex-
tremely difficult to conduct. To explore any 
"mechanism," we have to rely on certain model 
systems. In our studies, we believe that sufficient 
evidence exists to indicate the potential of skin 
PFK to act as an efficient (allosteric) regulator 
of glycolysis. 
At any rate, studies on the regulatory mech-
anisms in the metabolism of skin have been ex-
tremely limited. We look forward to new de-
velopments and knowledge in this field. 
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Dear Sir: 
The paper entitled "Effects of Long Ultra-
violet Rays on Human Skin: Photoprotective or 
Photoaugmentative?" by Willis, Kligman, and 
Epstein in volume 59, page 416, December 1972, 
contains some valuable data and perhaps heralds 
a resurgence of interest in the effects of long 
wavelength ultraviolet on human skin. 
However, some explanation of what appears to 
be selective literature citing is required. Van 
der Leun and Stoop [1] are quoted as demon-
strating photorecovery of ultraviolet erythema 
when artificial erythemic radiation is followed by 
filtered sunlight exposure. Willis, Kligman, and 
Epstein deny this in passing in their discussion 
with no experimental data. More importantly, 
they disregard the finding of Van der Leun and 
Stoop that when 300 nm radiation is used as 
erythema producing radiation, preceded by ex-
posure to filtered sunlight, the erythema thresh-
old is reduced by a factor of 1.4. 
It is difficult to understand why this piece of 
work should have been overlooked by the authors 
when it backs up so well their plea for greater 
consideration of the effects of long wavelength 
ultraviolet radiation. 
Yours etc. 
B. E. Johnson, Ph.D. 
Lecturer in Photobiology 
The University of Dundee 
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This letter was submitted to Dr. Willis who of-
fers the following reply: 
The authors wish to thank Dr. Johnson for his 
comments concerning our paper entitled "Effects 
of Long Ultraviolet Rays on Human Skin: Pho-
toprotective or Photoaugmentative?". 
The purpose of citing the reference of Drs. Van 
der Leun and Stoop was to make it very clear 
that photorecovery as demonstrated in their 
studies is not apparent under natural environmen-
tal conditions. In fact, the very opposite effect 
will be observed regardless of the sequence of 
exposures to filtered and unfiltered sunlight. 
We agree with Dr. Johnson that Van der Leun 
and Stoop's finding of a reduced cutaneous 
erythema threshold, when exposure to erythema-
genic (300 nm) radiation is preceded by expo-
sure to filtered sunlight, does correlate with cer-
tain of our experimental findings. 
